Online citations, reference lists, and bibliographies.
← Back to Search

PREPARATION AND IN-VITRO EVALUATION OF SODIUM ALGINATE MICROSPHERES CONTAINING DIPHTHERIA TOXOID AS NEW VACCINE DELIVERY

A. Mokaram, S. A. Mortazavi, N. M. Dounighi, H. Z. Alfagharian, M. Alonso
Published 2008 · Chemistry

Save to my Library
Download PDF
Analyze on Scholarcy
Share
During last two decades, polysaccharides such as alginate (Alg) alone and in combination with other biopolymers are widely used in vaccine and drug delivery systems. The aim of the present work was to investigate the potential utility of microparticles made of alginate (Alg) as new vehicles for improving nasal vaccine delivery. For this purpose, diphtheria toxoid (DT) was chosen as a model antigen. DT was entrapped within microparticles made of Alg of different molecular weight cross-linked using 1M CaCl2 or 3.75 %w/w CaCl2 in n-octanol. DT-loaded microparticles were characterized for their size, loading efficiency and in vitro release of toxoid. The resulting microparticles had a size, which varied depending on formulation conditions and Alg Mw. The results of the in vitro release studies displayed a biphasic release of toxoid, the intensity of the first phase being less pronounced for microparticles cross linked with aqueous CaCl2 than octanolic CaCl2.
This paper references
10.1016/J.JCONREL.2003.08.019
Oral colon-specific drug delivery for bee venom peptide: development of a coated calcium alginate gel beads-entrapped liposome.
L. Xing (2003)
10.1080/026520499289022
Calcium alginate microparticles for oral administration: II. Effect of formulation factors on drug release and drug entrapment efficiency.
F. Acartürk (1999)
10.1016/S0378-5173(99)00173-8
Microencapsulation of lipophilic drugs in chitosan-coated alginate microspheres.
A. Ribeiro (1999)
10.1201/b19309
Encyclopedia of Pharmaceutical Technology
J. Swarbrick (2006)
10.1080/0265204021000058438
Alginate encapsulation of genetically engineered mammalian cells: comparison of production devices, methods and microcapsule characteristics.
S. Koch (2003)
10.1023/A:1018908705446
Enhancement of Nasal Absorption of Insulin Using Chitosan Nanoparticles
R. Fernández-Urrusuno (2004)
10.1016/J.JCONREL.2004.07.030
Transmucosal macromolecular drug delivery.
C. Prego (2005)
10.1016/S0378-5173(96)04723-0
Oral controlled release of melatonin using polymer-reinforced and coated alginate beads
B. Lee (1996)
10.1016/0378-5173(93)90221-Z
Preparation of chitosan-reinforced alginate gel beads — effects of chitosan on gel matrix erosion
Y. Murata (1993)
10.1080/02652040110055621
Protein immobilization in crosslinked alginate microparticles
G. Coppi (2002)
Gapped BLAST and PSI-BLAST: A new
D. Lipman (1997)
MICRO/NANOENCAPSULATION OF PROTEINS WITHIN ALGINATE/CHITOSAN MATRIX BY SPRAY DRYING
Burak I. Erdinc (2007)
10.1007/BF02931086
DNA/PEI/Alginate polyplex as an efficientin vivo gene delivery system
Ge Jiang (2007)
10.1016/S1461-5347(00)00281-9
Intranasal vaccines: forthcoming challenges.
Partidos (2000)
10.1111/j.2042-7158.1993.tb05532.x
Immune Response to Nasal Delivery of Antigenically Intact Tetanus Toxoid Associated with Poly(l‐lactic acid) Microspheres in Rats, Rabbits and Guinea‐pigs
A. Almeida (1993)
10.1016/S0378-5173(00)00560-3
Survival and stability of bifidobacteria loaded in alginate poly-l-lysine microparticles.
J. H. Cui (2000)
10.1093/INFDIS/167.3.752
Microencapsulated human parainfluenza virus induces a protective immune response.
R. Ray (1993)
10.1016/0142-9612(96)84680-1
Alginate polycation microcapsules. I. Interaction between alginate and polycation.
B. Thu (1996)
10.1016/J.JCONREL.2004.07.020
Application of "ATTEMPTS" for drug delivery.
S. S. Naik (2005)
Nasal drug
Merkus (1994)
Nasal drug delivery : trends and perspectives
F. W. H. M. Merkus (1994)
10.1016/J.EJPB.2003.09.006
Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice.
A. Vila (2004)
10.1080/0265204031000140796
Beneficial effects of human serum albumin on stability and functionality of alginate microcapsules fabricated in different ways.
S. Schneider (2003)
10.2165/00128415-200711590-00025
Calcium alginate
DR.HARIKRISHNA K. R. Nair (2007)
10.1016/J.VACCINE.2005.07.053
Lipid microparticles for mucosal immunization against hepatitis B.
Surbhi Saraf (2006)
10.22037/IJPR.2010.590
PREPARATION AND EVALUATION OF DIPHTHERIA TOXOID-CONTAINING MICROSPHERES
S. A. Mortazavi (2004)
10.3109/02652049209021245
Drug encapsulation in alginate microspheres by emulsification.
L. Wan (1992)
10.1016/0264-410X(95)00184-3
Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+ cytotoxic T lymphocytes and CD4+ Th1 cells.
A. Moore (1995)
10.1080/026520499289329
Stability of chitosan and poly-L-lysine membranes coating DNA-alginate beads when exposed to hydrolytic enzymes.
D. Quong (1999)
10.1080/0265204031000093069
Formation of alginate microspheres produced using emulsification technique.
P. Heng (2003)
10.1016/J.JCONREL.2004.05.009
Hydrophobically modified alginate hydrogels as protein carriers with specific controlled release properties.
M. Léonard (2004)
10.1016/S0264-410X(97)00249-1
Intra nasal administration of poly-lactic acid microsphere co-encapsulated Yersinia pestis subunits confers protection from pneumonic plague in the mouse.
J. Eyles (1998)
10.1080/026520400417621
Sustained release properties of alginate microspheres and tabletted microspheres of diclofenac sodium
A. Çevik (2000)
10.1128/IAI.63.4.1195-1200.1995
Adjuvanticity and protective immunity elicited by Bordetella pertussis antigens encapsulated in poly(DL-lactide-co-glycolide) microspheres.
R. Shahin (1995)
10.2165/00003088-198917050-00001
Intranasal Drug Delivery
A. Pontiroli (1989)
10.1002/JPS.2600820215
Microencapsulation of drugs with aqueous colloidal polymer dispersions.
R. Bodmeier (1993)
10.1016/J.EJPS.2003.10.001
Biocompatibility and integrin-mediated adhesion of human osteoblasts to poly(DL-lactide-co-glycolide) copolymers.
R. Di Toro (2004)
10.3109/02652049709006808
Effect of cellulose derivatives on alginate microspheres prepared by emulsification.
L. Chan (1997)
10.22092/ARI.2006.103722
Preparation and evaluation of chitosan nanoparticles containing Diphtheria toxoid as new carriers for nasal vaccine delivery in mice
A. Mokarram (2006)
10.1111/j.2042-7158.1996.tb05872.x
Prolonged Immune Response Evoked by a Single Subcutaneous Injection of Microcapsules Having a Monophasic Antigen Release
H. Sah (1996)
10.1016/j.jconrel.2005.10.019
Incorporation of protein-eluting microspheres into biodegradable nerve guidance channels for controlled release.
Alex Goraltchouk (2006)
10.1016/S0168-3659(96)01612-4
Pulsed dextran release from calcium-alginate gel beads
A. Kikuchi (1997)
10.3109/02652049809008245
Preparation and tabletting of dipyridamole alginate-Eudragit microspheres.
A. Gürsoy (1998)
10.1023/A:1012128907225
Chitosan and Chitosan/Ethylene Oxide-Propylene Oxide Block Copolymer Nanoparticles as Novel Carriers for Proteins and Vaccines
P. Calvo (2004)
Gapped BLAST and PSIBLAST: a new generation of protein database search programs
S. F. Altschul (1997)
10.1016/J.ADDR.2006.01.002
Mucosal delivery of vaccine antigens and its advantages in pediatrics.
M. T. D. Magistris (2006)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar